Rhythm Pharmaceuticals
RYTM
RYTM
227 hedge funds and large institutions have $3.42B invested in Rhythm Pharmaceuticals in 2025 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 86 increasing their positions, 69 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
3.45% less ownership
Funds ownership: 105.63% → 102.18% (-3.5%)
6% less capital invested
Capital invested by funds: $3.63B → $3.42B (-$209M)
36% less funds holding in top 10
Funds holding in top 10: 11 → 7 (-4)
Holders
227
Holding in Top 10
7
Calls
$21.5M
Puts
$3.46M
Top Buyers
| 1 | +$83.4M | |
| 2 | +$71M | |
| 3 | +$27.2M | |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
+$23.9M |
| 5 |
SL
Siren LLC
Greenwich,
Connecticut
|
+$14.7M |
Top Sellers
| 1 | -$63.1M | |
| 2 | -$60M | |
| 3 | -$53M | |
| 4 |
Primecap Management
Pasadena,
California
|
-$41.5M |
| 5 |
BBA
Baker Bros. Advisors
New York
|
-$25.4M |